FDA Approved: KEPPRA — Supplemental Application (UCB, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for KEPPRA (levetiracetam) submitted by UCB, Inc., resulting in updated labeling for the drug. Keppra is used to tre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Juvenile Myoclonic Epilepsy
• Partial-onset Seizures

Drugs mentioned

• Keppra (levetiracetam)

Snippet

SUPPL AP for KEPPRA (LEVETIRACETAM)